Elucidation of the mechanism enabling tumor selective prodrug monotherapy

Cancer Research

Volumn 58, Issue 6, 1998, Pages 1195-1201

  Bosslet, Klaus ^a   Straub, Rainer ^a   Blumrich, Matthias ^a   Czech, Joerg ^a   Gerken, Manfred ^a,f   Sperker, Bernhard ^b   Kroemer, Heyo K ^b   Gesson, Jean Pierre ^c   Koch, Michel ^d   Monneret, Claude ^e  

^a Behringwerke AG   (Germany)

^b DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^c UNIVERSITÉ DE POITIERS   (France)

^d Laboratoire de Pharmacognogsie   (France)

^e INSTITUT CURIE   (France)

^f SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA GLUCURONIDASE; GLUCURONYL SPACER DOXORUBICIN; N (4 BETA GLUCURONYL 3 NITROBENZYLOXYCARBONYL)DOXORUBICIN; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ARTICLE; CANCER RESISTANCE; CRYOPRESERVATION; DRUG DESIGN; DRUG MECHANISM; DRUG SELECTIVITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; DOXORUBICIN; GLUCURONIDASE; HAPLORHINI; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PRODRUGS;

EID: 0032521438     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Anderson, J. H., Warren, H. W., and McArdle, C. S. Clinical and pharmacokinetic advantages of new drug delivery methods for the treatment of liver tumours. Clin. Pharmacokinet., 27: 191-201, 1994.
2. Thorpe, P. E., and Burrows, F. J. Antibody-directed targeting of the vasculature of solid tumors. Breast Cancer Res. Treat., 36: 237-251, 1995.
3. Guaglianone, P., Chen, K., DelaFlor-Weiss, E., Hanisch, R., Jeffers, S., Sharma, D., and Muggia, F. Phase I and pharmacologic study of liposomal daunorubicin (DaunoXome). Invest. New Drugs, 12: 103-110, 1994.
4. Bosslet, K., Czech, J., and Hoffmann, D. A novel one-step tumor-selective prodrug activation system. Tumor Targeting, 1: 45-50, 1995.
5. Bosslet, K., Straub, R., Gerken, M., Petrul, H., Czech, J., Florent, J. C., Koch, M., Tillequin, F., Schmidt, C., Monneret, C., and Gesson, J. P. Neue Ansätze zur spezifischen Antitumor-Behandlung: ADEPT, FMPA und PMT. 4. Salzburger Symposium zur Lebensqualität chronisch Kranker, pp. 123-130. New York: Georg Thieme Verlag Stuttgart, 1996.
6. Murray, G. I., Burke, M. D., and Ewen, S. W. B. Enzyme histochemistry on freeze-dried resin-embedded tissue. J. Histochem. Cytochem., 37: 643-652, 1989.
7. Heyderman, E. Immunoperoxidase technique in histology: applications, methods and controls. J. Clin. Pathol., 323: 971, 1979.
8. Bhardwaj, R. S., Zotz, C., Zwadlo-Klarwasser, G., Roth, J., Goebeler, M., Mahnke, K., Falk, M., Meinhardus-Hager, G., and Sorg, C. The calcium-binding proteins MRP8 and MRP14 form a membrane-associated heterodimer in a subset of monocytes/macrophages present in acute but absent in chronic inflammatory lesions. Eur. J. Immunol., 22: 1891-1897, 1992.
9. Zwadlo, G., Schlegel, R., and Sorg, C. A monoclonal antibody to a subset of human monocytes found only in the peripheral blood and inflammatory tissues. J. Immunol. 2: 512-518, 1986.
10. Herlyn, M., Steplewski, Z., Herlyn, D., and Koprowski, H. Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. Proc. Natl. Acad. Sci. USA, 76: 1438-1442, 1979.
11. Bosslet, K., Lueben, G., Schwarz, A., Hundt, E., Harthus, H. P., Seiler, F. R., Muhrer, C., Kloeppel, G., Kayser, K., and Sedlacek, H. H. Immunohistochemical localization and molecular characteristics of three monoclonal antibody-defined epitopes detectable on carcinoembryonic antigen (CEA). Int. J. Cancer., 36: 75-84, 1985.
12. Bosslet, K., Czech, J., and Hoffmann, D. Tumor-selective prodrug activation by fusion protein-mediated catalysis. Cancer Res., 54: 2151-2159, 1994.
13. Deng, G. R., and Wu, R. Terminal transferase: use in the tailing of DNA and for in vitro mutagenesis. Methods Enzymol., 100: 96-116, 1983.
14. Florent, J. C., Gaudel, G., Mitaku, S., Monneret, C., Gesson, J. P., Jacquesy, J. C., Mondon, J., Martine, C., Renoux, B., Andrianomenjanahary, S., Michel, S., Koch, M., Tillequin, F., Gerken, M., Czech, J., Straub, R., and Bosslet, K., Prodrugs of anthracyclines for use in antibody-directed enyzme prodrug therapy. J. Med. Chem., in press, 1998.
15. Muerdter, T. E., Sperker, B., Kivistö, K. T., Clellan, M. Mc., Fritz, P., Friedel, G., Linder, A., Bosslet, K., Toomes, H., Dierkesmann, R., and Kroemer, H. K. Enhanced uptake of doxorubicin into bronchial carcinoma: β-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR 1826) at the tumor site. Cancer Res. 57: 2440-2445, 1997.
16. Burtles, S. S., Newell, D. R., Henrar, R. E. C., and Connors, T. A. Revisions of general guidelines for the preclinical toxicology of new cytotoxic anticancer agents in Europe. Eur. J. Cancer, 31: 408-410, 1995.
17. Freireich, E. J., Gehan, E. A., Rall, D. P., Schmidt, L. H., and Skipper, H. E. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, monkey and man. Cancer Chemother. Rep., 50: 219-244, 1966.
18. Seligman, A. M., Tsou, K. C., Rutenberg, S. H., and Cohen, R. B. Histochemical demonstration of β-glucuronidase with a synthetic substrate. J. Histochem. Cytochem., 2: 209-229, 1954.
19. Mazue, G., Iatropoulos, M., Imondi, A., Castellino, S., Brughera, M., Podesta, A. Della Torre, P., and Moneta, D. Anthracyclines. A review of general and special toxicity studies. Int. J. Oncol., 7: 713-726, 1995.
20. Iatropoulos, M. J. Anthracycline cardiomyopathy: predictive value of animal models. Cancer Treat. Symp., 3: 3-17, 1984.
21. Bagshawe, K. D. Antibody-directed enzyme prodrug therapy. Clin. Pharmacokinet., 27: 368-376, 1994.
22. Osaki, T., Tanio, Y., Tachibana, I., Hosoe, S., Kumagai, T., Kawase, I., Oikawa, S., and Kishimoto, T. Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res., 54: 5258-5261, 1994.
23. Duncan, R. Drug-polymer conjugates: potential for improved chemotherapy. Anti-cancer Drugs, 3: 175-210, 1992.
24. Papahadjopoulos, D., Allen, T. M., Gabizon, A., Mayhew, E., Matthay, K., Huang, S. K., Lee, K-D., Woodle, M. C., Lasic, D. D., Redemann, C., and Martin, F. J. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. USA, 88: 11460-11464, 1991.
25. Sperker, B., Muerdter, T. E., Schick, M., Eckhardt, K., Bosslet, K., and Kroemer, H. K. Interindividual variability in expression and activity of human β-glucuronidase in liver and kidney: consequences for drug metabolism. J. Pharmacol. Exp. Ther., 281: 914-920, 1997.
26. Fishman, W. H., and Anlyan, A. J. The presence of high β-glucuronidase activity in cancer tissue. J. Biol. Chem., 169: 449-450, 1947.
27. Fishman, W. H., Anlyan, A. J., and Gordon, E. β-Glucuronidase activity in human tissues. Some correlations with processes of malignant growth and with the physiology of reproduction. Cancer Res., 12: 808-817, 1947.
28. Gesson, J. P., Jacquesy, J. C., Mondon, M., Petit, P., Renoux, B., Andrianomenjanahary, S., Dufat-Trinh Van, H., Koch, M., Michel, S., Tillequin, F., Florent, J. C., Monneret, C., Bosslet, K., Czech, J., and Hoffmann, D. Prodrugs of anthracyclines for chemotherapy by use of enzyme-monoclonal antibody conjugates. Anticancer Drug Design, 9: 409-423, 1994.
29. Schmidt, F., Florent, J-C., Monneret, C., Straub, R., Czech, J., Gerken, M., and Bosslet, K. Glucuronide prodrugs of hydroxy compounds for antibody directed enzyme prodrug therapy (ADEPT): a phenol nitrogen mustard carbamate. Bioorg. Med. Chem. Lett., 7: 1071-1076, 1997.
30. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
31. Thorpe, P. E., and Burrows, F. J. Antibody-directed targeting of the vasculature of solid tumors. Breast Cancer Res. Treat., 36: 237-251, 1995.
32. Person, C. M., and Wood, F. D. Studies of polyarthritis and other lesions induced in rats by injection of myobacterial adjuvant. Arthritis Rheum., 2: 440-458, 1959.
33. Collins, F. M., and Mackaness, G. B. Delayed hypersensitivity and arthus reactivity in relation to host resistance in salmonella infected mice. J. Immunol., 101: 830-645, 1968.
34. Ono, K., and Lindsey, E. S. Improved technique of heart transplantation in rats. J. Thorac. Cardiovasc. Surg., 57: 225-231, 1969.